Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald P Taylor

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Blood|October 26, 2013
Gnawing at Metchnikoff's paradigmRonald P Taylor
Blood|May 13, 2017
Neutrophils: positive or negative?Ronald P Taylor
Leukemia Research|May 3, 2005
Use of biological response modifiers to enhance the action of RituximabRonald P Taylor
Haematologica|February 8, 2006
Of mice and mechanisms: identifying the role of complement in monoclonal antibody-based immunotherapyRonald P Taylor
Blood|May 2, 2024
T cells reinforce NK cell-mediated ADCCRonald P Taylor
Blood|March 30, 2019
Null donors favor prepared immunologistsRonald P Taylor
Antibodies (Basel, Switzerland)|August 27, 2021
Special Issue: The Role of Complement in Cancer ImmunotherapyRonald P Taylor
Antibodies (Basel, Switzerland)|October 31, 2020
The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbsJosée Golay, Ronald P Taylor
Seminars in Hematology|March 31, 2010
Antigenic modulation and rituximab resistanceRonald P Taylor, Margaret A Lindorfer
Antibodies (Basel, Switzerland)|September 9, 2020
How Do mAbs Make Use of Complement to Kill Cancer Cells? The Role of Ca<sup>2</sup>Ronald P Taylor, Margaret A Lindorfer
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Blood|October 26, 2013
Gnawing at Metchnikoff's paradigmRonald P Taylor
Blood|May 13, 2017
Neutrophils: positive or negative?Ronald P Taylor
Leukemia Research|May 3, 2005
Use of biological response modifiers to enhance the action of RituximabRonald P Taylor
Haematologica|February 8, 2006
Of mice and mechanisms: identifying the role of complement in monoclonal antibody-based immunotherapyRonald P Taylor
Blood|May 2, 2024
T cells reinforce NK cell-mediated ADCCRonald P Taylor
Blood|March 30, 2019
Null donors favor prepared immunologistsRonald P Taylor
Antibodies (Basel, Switzerland)|August 27, 2021
Special Issue: The Role of Complement in Cancer ImmunotherapyRonald P Taylor
Antibodies (Basel, Switzerland)|October 31, 2020
The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbsJosée Golay, Ronald P Taylor
Seminars in Hematology|March 31, 2010
Antigenic modulation and rituximab resistanceRonald P Taylor, Margaret A Lindorfer
Antibodies (Basel, Switzerland)|September 9, 2020
How Do mAbs Make Use of Complement to Kill Cancer Cells? The Role of Ca<sup>2</sup>Ronald P Taylor, Margaret A Lindorfer
Pageof 10